Response by Flynn, Heather A. & Marcus, Sheila M.
WE THANK MS. BENNETT AND DR. EINARSON fortheir careful analysis of our paper. They
have correctly noted that the CES-D in the refer-
enced studies1,2 were indeed conducted with
postpartum not pregnant women. In our own
study using the CES-D to detect elevated de-
pression during pregnancy, we found the inter-
nal consistency of this measure to be comparable
(Chronbach’s alpha 5 0.89) to the Applebaum
study of postpartum women.1 We also agree that
the sensitivity and specificity of the CES-D (as ad-
ministered prenatally) to detect major depressive
disorder (MDD) has not been established and re-
quires further study.
Bennett and Einarson3 made a broader point,
questioning the validity of the CES-D as a pre-
natal screening tool to determine at-risk women
who may benefit from follow-up. This point war-
rants further consideration. First, studies have
found elevated symptoms of depression during
pregnancy as measured by the CES-D to be re-
lated to poor outcomes, such as restricted fetal
growth4 (among lower SES women and using a
cutoff point of $16), spontaneous preterm birth,5
and impaired neonatal neuromotor performance
among depressed women.6 Second, the use of the
CES-D (using the $16 cutoff) prenatally in stud-
ies has resulted in expected rates (i.e., similar to
studies using other screening tools) of elevated
depression (Marcus et al.,7 20%; Hoffman and
Hatch,4 19.9%–30.6% depending on stage of preg-
nancy; Wu et al.8 15.6%). These points (good in-
ternal consistency, association in some studies
with negative outcomes, the result of expected
rates of elevated symptomatology) suggest that it
is reasonable to use the CES-D as a first-stage
screening with the aim of identifying women who
may benefit from further assessment, follow-up,
and possibly intervention. However, there may
be measures (such as the EPDS; Edinburgh Post-
natal Depression Scale) that prove to have supe-
rior sensitivity, specificity, and positive predic-
tive value in identifying MDD and other
unwanted outcomes in this population.
Further research on this and on the utility of
distinguishing the nature and measurement of
symptoms of depression prenatally vs. postna-
tally is needed. We are delighted that issues re-
lated to the improved detection and treatment of
depression in obstetric populations (both prena-
tally and postnatally) are receiving careful atten-
tion and appreciate the opportunity to engage in
the discussion.
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